ID   PD2R_HUMAN              Reviewed;         359 AA.
AC   Q13258; G3V5L3; Q13250; Q13251; Q1ZZ52;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   27-MAR-2024, entry version 194.
DE   RecName: Full=Prostaglandin D2 receptor;
DE            Short=PGD receptor;
DE            Short=PGD2 receptor;
DE   AltName: Full=Prostanoid DP receptor;
GN   Name=PTGDR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=7642548; DOI=10.1074/jbc.270.32.18910;
RA   Boie Y., Sawyer N., Slipetz D.M., Metters K.M., Abramovitz M.;
RT   "Molecular cloning and characterization of the human prostanoid DP
RT   receptor.";
RL   J. Biol. Chem. 270:18910-18916(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RA   Martin A.L., Kaighin V.A., Aronstam R.S.;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-7; GLU-198; ALA-301 AND
RP   GLN-332.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=6302737; DOI=10.1016/0090-6980(83)90131-4;
RA   Town M.H., Casals-Stenzel J., Schillinger E.;
RT   "Pharmacological and cardiovascular properties of a hydantoin derivative,
RT   BW 245 C, with high affinity and selectivity for PGD2 receptors.";
RL   Prostaglandins 25:13-28(1983).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11082108; DOI=10.1038/sj.bjp.0703686;
RA   Sharif N.A., Williams G.W., Davis T.L.;
RT   "Pharmacology and autoradiography of human DP prostanoid receptors using
RT   [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.";
RL   Br. J. Pharmacol. 131:1025-1038(2000).
RN   [9]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO ASRT1.
RX   PubMed=15496624; DOI=10.1056/nejmoa031785;
RA   Oguma T., Palmer L.J., Birben E., Sonna L.A., Asano K., Lilly C.M.;
RT   "Role of prostanoid DP receptor variants in susceptibility to asthma.";
RL   N. Engl. J. Med. 351:1752-1763(2004).
CC   -!- FUNCTION: Receptor for prostaglandin D2 (PGD2). The activity of this
CC       receptor is mainly mediated by G(s) proteins that stimulate adenylate
CC       cyclase, resulting in an elevation of intracellular cAMP. A
CC       mobilization of calcium is also observed, but without formation of
CC       inositol 1,4,5-trisphosphate (By similarity). Involved in PLA2G3-
CC       dependent maturation of mast cells. PLA2G3 is secreted by immature mast
CC       cells and acts on nearby fibroblasts upstream to PTDGS to synthesize
CC       PGD2, which in turn promotes mast cell maturation and degranulation via
CC       PTGDR (By similarity). {ECO:0000250|UniProtKB:P70263,
CC       ECO:0000250|UniProtKB:Q9R261}.
CC   -!- INTERACTION:
CC       Q13258; Q9NZ52: GGA3; NbExp=5; IntAct=EBI-20731195, EBI-447404;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13258-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13258-2; Sequence=VSP_055141, VSP_055142;
CC   -!- TISSUE SPECIFICITY: Expressed in retinal choroid, ciliary epithelium,
CC       longitudinal and circular ciliary muscles, iris, small intestine and
CC       platelet membranes. {ECO:0000269|PubMed:11082108,
CC       ECO:0000269|PubMed:6302737}.
CC   -!- DISEASE: Asthma-related traits 1 (ASRT1) [MIM:607277]: Asthma-related
CC       traits include clinical symptoms of asthma, such as coughing, wheezing,
CC       dyspnea, bronchial hyperresponsiveness as assessed by methacholine
CC       challenge test, serum IgE levels, atopy and atopic dermatitis.
CC       {ECO:0000269|PubMed:15496624}. Note=Disease susceptibility is
CC       associated with variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/apobec3f/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U31098; AAC50176.1; -; Genomic_DNA.
DR   EMBL; U31099; AAC50177.1; -; mRNA.
DR   EMBL; U31332; AAC50178.1; -; Genomic_DNA.
DR   EMBL; EF577397; ABQ52417.1; -; mRNA.
DR   EMBL; DQ418808; ABD72608.1; -; Genomic_DNA.
DR   EMBL; AL365475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65657.1; -; Genomic_DNA.
DR   EMBL; BC040968; AAH40968.1; -; mRNA.
DR   CCDS; CCDS61454.1; -. [Q13258-2]
DR   CCDS; CCDS9707.1; -. [Q13258-1]
DR   PIR; I39153; I39153.
DR   RefSeq; NP_000944.1; NM_000953.2. [Q13258-1]
DR   RefSeq; NP_001268398.1; NM_001281469.1. [Q13258-2]
DR   RefSeq; XP_005267948.1; XM_005267891.3. [Q13258-1]
DR   AlphaFoldDB; Q13258; -.
DR   SMR; Q13258; -.
DR   BioGRID; 111701; 10.
DR   IntAct; Q13258; 5.
DR   MINT; Q13258; -.
DR   STRING; 9606.ENSP00000303424; -.
DR   BindingDB; Q13258; -.
DR   ChEMBL; CHEMBL4427; -.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugBank; DB00374; Treprostinil.
DR   DrugCentral; Q13258; -.
DR   GuidetoPHARMACOLOGY; 338; -.
DR   SwissLipids; SLP:000001561; -.
DR   GlyCosmos; Q13258; 3 sites, No reported glycans.
DR   GlyGen; Q13258; 3 sites.
DR   iPTMnet; Q13258; -.
DR   PhosphoSitePlus; Q13258; -.
DR   BioMuta; PTGDR; -.
DR   DMDM; 2495009; -.
DR   EPD; Q13258; -.
DR   MassIVE; Q13258; -.
DR   PaxDb; 9606-ENSP00000303424; -.
DR   PeptideAtlas; Q13258; -.
DR   ProteomicsDB; 59257; -. [Q13258-1]
DR   Antibodypedia; 10764; 233 antibodies from 28 providers.
DR   DNASU; 5729; -.
DR   Ensembl; ENST00000306051.3; ENSP00000303424.2; ENSG00000168229.4. [Q13258-1]
DR   Ensembl; ENST00000553372.1; ENSP00000452408.1; ENSG00000168229.4. [Q13258-2]
DR   GeneID; 5729; -.
DR   KEGG; hsa:5729; -.
DR   MANE-Select; ENST00000306051.3; ENSP00000303424.2; NM_000953.3; NP_000944.1.
DR   UCSC; uc001wzq.3; human. [Q13258-1]
DR   AGR; HGNC:9591; -.
DR   CTD; 5729; -.
DR   DisGeNET; 5729; -.
DR   GeneCards; PTGDR; -.
DR   HGNC; HGNC:9591; PTGDR.
DR   HPA; ENSG00000168229; Tissue enhanced (intestine, lymphoid tissue).
DR   MalaCards; PTGDR; -.
DR   MIM; 604687; gene.
DR   MIM; 607277; phenotype.
DR   neXtProt; NX_Q13258; -.
DR   OpenTargets; ENSG00000168229; -.
DR   PharmGKB; PA285; -.
DR   VEuPathDB; HostDB:ENSG00000168229; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01050000244902; -.
DR   HOGENOM; CLU_045991_0_2_1; -.
DR   InParanoid; Q13258; -.
DR   OMA; NWHSNSC; -.
DR   OrthoDB; 5355693at2759; -.
DR   PhylomeDB; Q13258; -.
DR   TreeFam; TF324982; -.
DR   PathwayCommons; Q13258; -.
DR   Reactome; R-HSA-391908; Prostanoid ligand receptors.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   SignaLink; Q13258; -.
DR   SIGNOR; Q13258; -.
DR   BioGRID-ORCS; 5729; 21 hits in 1152 CRISPR screens.
DR   ChiTaRS; PTGDR; human.
DR   GeneWiki; Prostaglandin_D2_receptor; -.
DR   GenomeRNAi; 5729; -.
DR   Pharos; Q13258; Tclin.
DR   PRO; PR:Q13258; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q13258; Protein.
DR   Bgee; ENSG00000168229; Expressed in granulocyte and 108 other cell types or tissues.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0004956; F:prostaglandin D receptor activity; IBA:GO_Central.
DR   GO; GO:0001785; F:prostaglandin J receptor activity; IEA:Ensembl.
DR   GO; GO:0046085; P:adenosine metabolic process; IEA:Ensembl.
DR   GO; GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0030238; P:male sex determination; IEA:Ensembl.
DR   GO; GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0030431; P:sleep; IEA:Ensembl.
DR   CDD; cd15140; 7tmA_PGD2; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000376; Pglndn_D_rcpt.
DR   InterPro; IPR008365; Prostanoid_rcpt.
DR   PANTHER; PTHR11866; G-PROTEIN COUPLED RECEPTOR FAMILY 1 MEMBER; 1.
DR   PANTHER; PTHR11866:SF14; PROSTAGLANDIN D2 RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01788; PROSTANOIDR.
DR   PRINTS; PR00854; PRSTNOIDDPR.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
DR   Genevisible; Q13258; HS.
PE   1: Evidence at protein level;
KW   Alternative splicing; Asthma; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Mast cell degranulation;
KW   Membrane; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..359
FT                   /note="Prostaglandin D2 receptor"
FT                   /id="PRO_0000070047"
FT   TOPO_DOM        1..21
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        22..42
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        43..59
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..80
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        81..107
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        108..128
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        129..150
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..195
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        196..216
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        217..262
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        263..283
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        284..310
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        311..331
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..359
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        105..183
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VAR_SEQ         283..296
FT                   /note="YRAYYGAFKDVKEK -> AFVPGVPAKTPGSR (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055141"
FT   VAR_SEQ         297..359
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055142"
FT   VARIANT         7
FT                   /note="R -> C (in dbSNP:rs41311442)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_033482"
FT   VARIANT         198
FT                   /note="G -> E (in dbSNP:rs41312444)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_054975"
FT   VARIANT         301
FT                   /note="E -> A (in dbSNP:rs41312504)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_033483"
FT   VARIANT         332
FT                   /note="R -> Q (in dbSNP:rs41312506)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_054976"
SQ   SEQUENCE   359 AA;  40271 MW;  098F89F08D0BE12A CRC64;
     MKSPFYRCQN TTSVEKGNSA VMGGVLFSTG LLGNLLALGL LARSGLGWCS RRPLRPLPSV
     FYMLVCGLTV TDLLGKCLLS PVVLAAYAQN RSLRVLAPAL DNSLCQAFAF FMSFFGLSST
     LQLLAMALEC WLSLGHPFFY RRHITLRLGA LVAPVVSAFS LAFCALPFMG FGKFVQYCPG
     TWCFIQMVHE EGSLSVLGYS VLYSSLMALL VLATVLCNLG AMRNLYAMHR RLQRHPRSCT
     RDCAEPRADG REASPQPLEE LDHLLLLALM TVLFTMCSLP VIYRAYYGAF KDVKEKNRTS
     EEAEDLRALR FLSVISIVDP WIFIIFRSPV FRIFFHKIFI RPLRYRSRCS NSTNMESSL
//